SCHEMBL6015587

SCHEMBL6015587

CCn1c(SCc2ccccn2)nnc1-c1cc2ccccc2cc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
LMNA P02545 4/20 0.60
HTT P42858 2/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2C9 P11712 2/20 0.60
CYP2C19 P33261 2/20 0.60
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
RGS12 O14924 1/20 0.58
MAPK1 P28482 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
MAPT P10636 3/20 0.52
FPR1 P21462 1/20 0.52
GAA P10253 2/20 0.48
TSHR P16473 2/20 0.48
RAB9A P51151 2/20 0.47
KDM4E B2RXH2 2/20 0.47
GLA P06280 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14777942 0.81 ALDH1A1 (0.61) ALDH1A1LMNAHTTL3MBTL1CYP1A2
SCHEMBL6015613 0.78 KMT2A (0.65) ALDH1A1LMNAHTTL3MBTL1CYP1A2
SCHEMBL4207004 0.74 SMN1; SMN2 (0.66) ALDH1A1LMNAHTTL3MBTL1MAPT
SCHEMBL4215805 0.72 L3MBTL1 (0.46) ALDH1A1LMNAHTTL3MBTL1MAPT
SCHEMBL4206890 0.72 SMN1; SMN2 (0.58) ALDH1A1LMNAHTTL3MBTL1MEN1
SCHEMBL6408375 0.72 ALDH1A1 (0.56) ALDH1A1LMNAHTTL3MBTL1CYP1A2
SCHEMBL1864520 0.70 HSP90AA1 (0.52) ALDH1A1LMNAL3MBTL1MEN1KMT2A
SCHEMBL4212057 0.70 GAA (0.49) ALDH1A1LMNAHTTL3MBTL1MAPT
SCHEMBL4215752 0.70 HTT (0.67) ALDH1A1LMNAHTTCYP1A2CYP3A4
SCHEMBL4206997 0.69 ALDH1A1 (0.53) ALDH1A1LMNAHTTL3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054526-A2 CHEMOSENSORY RECEPTOR LIGAND-BASED THERAPIES ELCELYX THERAPEUTICS, INC. (US) 2012-04-26 WO disclosed